✦ LIBER ✦

214 POSTER Characterization of a recombinant, fully human monoclonal antibody directed against the human insulin-like growth factor-1 receptor

✍ Scribed by T. Schnitzer; K.-P. Kuenkele; F. Rebers; M. Van Vugt; C. Klein; M. Lanzendoerfer; O. Mundigl; P.W.H.I. Parren; J.G.J. van de Winkel; R. Schumacher

Book ID: 118623842
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 76 KB
Volume: 4
Category: Article
ISSN: 1359-6349
DOI: 10.1016/s1359-6349(06)70219-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Two New Monoclonal Antibodies against th

Two New Monoclonal Antibodies against the α Subunit of the Human Insulin-like Growth Factor-I Receptor

✍ S.L. Li; J. Kato; I.B. Paz; J. Kasuya; Y. Fujitayamaguchi 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 317 KB

A recombinant humanized anti-insulin-lik

A recombinant humanized anti-insulin-like growth factor receptor type I antibody (h7C10) enhances the antitumor activity of vinorelbine and anti-epidermal growth factor receptor therapy against human cancer xenografts

✍ Liliane Goetsch; Alexandra Gonzalez; Olivier Leger; Alain Beck; Petrus J. Pauwel 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 959 KB

## Abstract Interaction of insulin‐like growth factor receptor I (IGF‐IR) with its ligands has been reported to induce cell proliferation, transformation and blockade of cell apoptotic functions. IGF‐IR is overexpressed on numerous tumor cell types and its blockade could be of importance for anti‐c

648 POSTER A phase I dose-escalation stu

648 POSTER A phase I dose-escalation study of weekly IMC-A12, a fully human insulin like growth factor-I receptor (IGF-IR) IgG1 monoclonal antibody (Mab), in patients (pts) with advanced cancer

✍ C. Higano; M. Gordon; P. LoRusso; F. Fox; T. Katz; J. Roecker; E. Rowinsky; H. Y 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 59 KB

554 POSTER Pharmacokinetic (PK) and phar

554 POSTER Pharmacokinetic (PK) and pharmacodynamic (PD) results of Phase I studies of IMC-A12, a fully human insulin like growth factor-I receptor IgG1 monoclonal antibody, in patients with advanced solid malignancies

✍ M.L. Rothenberg; E. Poplin; P. LoRusso; E. Yu; J. Schwartz; F. Fox; J. Mehnert; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 73 KB

406 POSTER IMC-18F1, a recombinant human

406 POSTER IMC-18F1, a recombinant human monoclonal antibody (MAb) against the vascular endothelial growth factor receptor-1 (VEGFR-1), in the treatment of patients (pts) with advanced solid malignancies: A Phase 1 study

✍ S. Krishnamurthi; P.H.B. Goncalves; F. Fox; N. Hall; E. Rowinsky; J. Schwartz; H 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 81 KB

195 POSTER In vitro and in vivo inhibiti

195 POSTER In vitro and in vivo inhibition of functional responses at insulin-like growth factor-1/insulin hybrid receptors by h7C10, a novel humanized anti-IGF-1R monoclonal antibody

✍ T. Wurch; G. Pandini; B. Akla; N. Corvaia; A. Belfiore; L. Goetsch 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 56 KB